Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Norris

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Cell Death & Disease|June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cellsNabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Elife|December 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
American Journal of Medical Genetics. Part A|August 26, 2021
Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestryEmily Mira Warshauer, Adam Brown, Ignacia Fuentes, et al.
Pigment Cell & Melanoma Research|October 4, 2018
Frontiers in pigment cell and melanoma researchFabian V Filipp, Stanca Birlea, Marcus W Bosenberg, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Cell Death & Disease|June 10, 2020
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cellsNabanita Mukherjee, Jenette Skees, Kaleb J Todd, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Elife|December 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
American Journal of Medical Genetics. Part A|August 26, 2021
Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestryEmily Mira Warshauer, Adam Brown, Ignacia Fuentes, et al.
Pigment Cell & Melanoma Research|October 4, 2018
Frontiers in pigment cell and melanoma researchFabian V Filipp, Stanca Birlea, Marcus W Bosenberg, et al.
Pageof 8